Gara Jalqabaatti › Dhukkuba Kroonii › Ohio › Cleveland
Qorannoo klinikaalii Dhukkuba Kroonii Cleveland, OH keessatti
Qorannoo 19 Dhukkuba Kroonii f Cleveland fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.
Takkalaa qorannoo (Ingiliffa)
Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
Namoota walitti qabaa jiraSadarkaa 3
- Great Lakes Gastroenterology Research, LLC ( Site 5016), Mentor · Miili 22 fagaatti
Investigating the Effect of the Non-nutritive Sweetener Sucralose in Inflammatory Bowel Disease
Namoota walitti qabaa jiraHojjettoota fayyaa simatamoo
- University Hospitals Cleveland Medical Center, Cleveland
- UH Minoff Health Center, Chagrin Falls · Miili 17 fagaatti
A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
Namoota walitti qabaa jiraSadarkaa 4
- Great Lakes Gastroenterology Research, LLC, Mentor · Miili 22 fagaatti
Non-nutritive Sweeteners in Inflammatory Bowel Disease
Namoota walitti qabaa jiraHojjettoota fayyaa simatamoo
- University Hospitals Cleveland Medical Center, Cleveland
- UH Minoff Health Center, Chagrin Falls · Miili 17 fagaatti
A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
Namoota walitti qabaa jiraSadarkaa 3
- Great Lakes Gastroenterology Research, LLC, Mentor · Miili 22 fagaatti
A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease
Namoota walitti qabaa jiraSadarkaa 2
- Great Lakes Gastroenterology Research, LLC, Mentor · Miili 22 fagaatti
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
Namoota walitti qabaa jiraSadarkaa 3
- University Hospitals Cleveland Medical Center-Site Number: 8400073, Cleveland
A Study to Assess Adverse Events, Change in Disease Activity, and How Intravenous and Subcutaneous Risankizumab Moves Through the Body of Pediatric Participants With Moderately to Severely Active Crohn's Disease
Namoota walitti qabaa jiraSadarkaa 3
- Cleveland Clinic - Cleveland /ID# 256453, Cleveland
A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease
Namoota walitti qabaa jiraSadarkaa 4
- Great Lakes Gastroenterology Research, LLC, Mentor · Miili 22 fagaatti
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease
Namoota walitti qabaa jiraSadarkaa 3
- Great Lakes Gastroenterology Research, LLC, Mentor · Miili 22 fagaatti
Ultrasound-Guided Versus Standard Margin Selection in Ileocecal Resection of Terminal Ileal CD
Namoota walitti qabaa jira
- Cleveland Clinic, Cleveland
Crohn's Disease: Efficacy, Safety, and Pharmacokinetics of Upadacitinib in Pediatric Subjects With Moderately to Severely Active Crohn's Disease
Namoota walitti qabaa jiraSadarkaa 3
- UH Cleveland Medical Center /ID# 262188, Cleveland
A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)
Namoota walitti qabaa jiraSadarkaa 3
- University Children's Clinic, Cleveland
- Cleveland Clinic, Cleveland
Clinical, Imaging, and Endoscopic Outcomes of Children Newly Diagnosed With Crohn's Disease
Namoota walitti qabaa jiraSadarkaa 4
- UH/Rainbow Babies and Children's Hospital, Cleveland
A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)
Namoota walitti qabaa jiraSadarkaa 3
- University Hospitals Cleveland Medical Center - 11100 Euclid Ave, Cleveland
Precise Infliximab Exposure and Pharmacodynamic Control
Namoota walitti qabaa jiraSadarkaa 2/3
- Cleveland Clinic Children's Hospital, Cleveland
A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD)
Namoota walitti qabaa jiraSadarkaa 3
- University Hospitals Cleveland Medical Center, Cleveland
Treatment of Moderate to Severe Refractory Crohn's Disease
Namoota walitti qabaa jiraSadarkaa 1/2
- Cleveland Clinic, Cleveland
Development of a Novel Endoscopic Index and Patient-reported Outcome Measure for Clinical Trials in Participants With Permanent Ileostomy
Namoota walitti qabaa jiraQorannoo ilaalaa
- Cleveland Clinic Foundation, Cleveland
Qorannoo Dhukkuba Kroonii magaalota biroo keessatti
- New York City, NYQorannoo 35
- St. Louis, MOQorannoo 19
- Boston, MAQorannoo 19
- Miami, FLQorannoo 19
- Orlando, FLQorannoo 17
- Houston, TXQorannoo 17
- Atlanta, GAQorannoo 17
- Tyler, TXQorannoo 16
- San Diego, CAQorannoo 15
- San Antonio, TXQorannoo 15
- Los Angeles, CAQorannoo 15
- Philadelphia, PAQorannoo 13
Qorannoo biroo Cleveland keessatti
- Kansara Qara'a Non-Small CellQorannoo 43
- Saree (Gosoota Hunda)Qorannoo 36
- Saree OljooQorannoo 35
- Kansarii ProstateQorannoo 34
- Cufama OnneeQorannoo 33
- Kansara MetastatikiiQorannoo 30
- Kansarii OvariiQorannoo 30
- Dhibee QaraQorannoo 26
- Kansarii ColorectalQorannoo 24
- Dhibee Onneessaa fi DhiigaQorannoo 22
- Kansa EndometiriyaaliiQorannoo 20
- Leukemia Myeloidii HamaaQorannoo 20
Kanneen ClinicalTrials.gov irraa argaman, daataa 05-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.